Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 27421

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Z-VA-DL-D(OMe)-FMK (Z-VAD-FMK) is a pan-caspase inhibitor.1 It inhibits anti-Fas antibody-induced cleavage of caspase-3 and PARP in Jurkat T lymphocytes when used at a concentration of 0.5 μM. Z-VAD-FMK (50 μM) inhibits cell death induced by TNF-α and cycloheximide co-application in HeLa cells. It also inhibits radiation-induced increases in the number of TUNEL-positive neurons in the rat hypoglossal nucleus when administered intracerebroventricularly at a dose of 2 μg per animal.2
WARNING This product is not for human or veterinary use.
1. MX1013, a dipeptide caspase inhibitor with potent in vivo antiapoptotic activity. Br. J. Pharmacol. 140(2), 402-412 (2003).
2. Radiation-
Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell Chem. Biol. 30(9), P1090-P1103 (2022).
Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability. Nat. Chem. Biol. (2022).